US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AN2 Therapeutics, Inc.

1.12

-0.0200-1.75%

Post-market: 1.120.00000.00%16:00 EST

Volume:22.97K

Turnover:26.11K

Market Cap:30.69M

PE:-0.99

High:1.17

Open:1.12

Low:1.10

Close:1.14

52wk High:1.55

52wk Low:1.01

Shares:27.40M

Float Shares:19.16M

Volume Ratio:0.40

T/O Rate:0.12%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.1292

EPS(LYR):-1.7206

ROE:-45.91%

ROA:-28.35%

PB:0.51

PE(LYR):-0.65

Loading ...

Overview Company News Filings

AN2 Therapeutics Advances Chagas Disease and Oncology Programs and Reports Third Quarter 2025 Results

AN2 Therapeutics Q3 net loss narrows to $9.4 mln

Press Release: AN2 Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business and Scientific Highlights

REFILE-BUZZ-U.S. STOCKS ON THE MOVE-Guardant Health, Tower Semiconductor, GlobalFoundries

BUZZ-U.S. STOCKS ON THE MOVE-Instacart, Plug Power, Crypto stocks

AN2 Therapeutics, GSK Collaborate to Develop New Therapies for Tuberculosis

MT Newswires Live

Shares of AN2 Therapeutics up 1.8% After GSK Collaboration to Develop Tuberculosis Treatment

THOMSON REUTERS

BRIEF-AN2 Therapeutics Announces Research Collaboration With GSK

AN2 Therapeutics Partners with GSK to Develop Boron-Based Tuberculosis Treatments

AN2 Therapeutics Announces Research Collaboration With GSK to Advance Boron-Based Leurs-Inhibitors Targeting Tuberculosis (Tb)

THOMSON REUTERS

AN2 Therapeutics Inc. Officer Joshua M. Eizen Reports Disposal of Common Shares

AN2 Therapeutics CEO to Join Fireside Chat at Evercore HealthCONx Conference

AN2 Therapeutics Inc expected to post a loss of 22 cents a share - Earnings Preview

AN2 Therapeutics Gains 11%, Insider Trades Reap Benefit

Simply Wall St.

AN2 Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

AN2 Therapeutics Reports Q2 2025: Net Loss Decreases to $6.5M, Interest Income Drops Amid Lower Cash Balances

AN2 Therapeutics Initiates First-in-Human Clinical Trial for Potential Chagas Disease Cure, AN2-502998

AN2 Therapeutics Commences First-in-Human Clinical Trial of Oral AN2-502998 for Chagas Disease

THOMSON REUTERS

AN2 Therapeutics - Phase 2 Planning Underway With Dndi Collaboration; Initiation Expected in 2026, Data in 2027

THOMSON REUTERS

AN2 Therapeutics Inc expected to post a loss of 33 cents a share - Earnings Preview

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ANTX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ANTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANTX\",,,,,undefined,":{"symbol":"ANTX","market":"US","secType":"STK","nameCN":"AN2 Therapeutics, Inc.","latestPrice":1.12,"timestamp":1766178000000,"preClose":1.14,"halted":0,"volume":22967,"hourTrading":{"tag":"盘后","latestPrice":1.12,"preClose":1.12,"latestTime":"16:00 EST","volume":320,"amount":358.40000000000003,"timestamp":1766178001017},"delay":0,"floatShares":19164900,"shares":27402024,"eps":-1.129215,"marketStatus":"Post-Mkt","change":-0.02,"latestTime":"12-19 16:04:46 EST","open":1.12,"high":1.17,"low":1.1,"amount":26108.426,"amplitude":0.061404,"askPrice":1.16,"askSize":10,"bidPrice":1.1,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-1.129215,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1766192400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1648180800000,"exchange":"NASDAQ","adjPreClose":1.14,"postHourTrading":{"tag":"盘后","latestPrice":1.12,"preClose":1.12,"latestTime":"16:00 EST","volume":320,"amount":358.40000000000003,"timestamp":1766178001017},"volumeRatio":0.404174},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ANTX\",,,,,undefined,":{"symbol":"ANTX","floatShares":19164900,"roa":"-28.35%","roe":"-45.91%","lyrEps":-1.720551,"volumeRatio":0.404174,"shares":27402024,"dividePrice":0,"high":1.17,"amplitude":0.061404,"preClose":1.14,"low":1.1,"week52Low":1.01,"pbRate":"0.51","week52High":1.55,"institutionHeld":0,"latestPrice":1.12,"eps":-1.129215,"divideRate":0,"volume":22967,"delay":0,"ttmEps":-1.129215,"open":1.12,"prevYearClose":1.38,"prevWeekClose":1.2,"prevMonthClose":1.09,"prevQuarterClose":1.27,"fiveDayClose":1.2,"twentyDayClose":1.08,"sixtyDayClose":1.24},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ANTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"ANTX","fiscalQuarterEnding":"2025/09","expectedEps":-0.23,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-0.31},{"market":"US","date":"2025-08-12","symbol":"ANTX","fiscalQuarterEnding":"2025/06","expectedEps":-0.31,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.21}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ANTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ANTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1736485200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ANTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ANTX","date":"2025-12-18","current":-1.009551,"percent":0.660194,"low":-16.371108,"twenty":-8.06829,"median":-1.982641,"eighty":-0.721316,"high":-0.452319,"avg":-4.055378,"sd":3.873945,"marketCap":30964287},"quantilePoints":[{"date":"2022-03-25","current":-13.396124,"twenty":-13.256944,"median":-13.048173,"eighty":-12.797512,"marketCap":288592704},{"date":"2022-04-01","current":-13.735377,"twenty":-13.389165,"median":-13.082968,"eighty":-13.048173,"marketCap":295901220},{"date":"2022-04-08","current":-13.126462,"twenty":-13.389165,"median":-13.126462,"eighty":-13.048173,"marketCap":282783370},{"date":"2022-04-14","current":-12.195692,"twenty":-13.35611,"median":-13.056872,"eighty":-12.282634,"marketCap":262731799},{"date":"2022-04-22","current":-12.674125,"twenty":-13.265642,"median":-13.043824,"eighty":-12.188734,"marketCap":273038682},{"date":"2022-04-29","current":-13.596196,"twenty":-13.35611,"median":-13.048173,"eighty":-12.282634,"marketCap":292902855},{"date":"2022-05-06","current":-16.371108,"twenty":-13.735377,"median":-13.082968,"eighty":-12.639148,"marketCap":352682772},{"date":"2022-05-13","current":-12.634954,"twenty":-13.707541,"median":-13.048173,"eighty":-12.337661,"marketCap":343038993},{"date":"2022-05-20","current":-7.432326,"twenty":-13.556182,"median":-13.043824,"eighty":-12.180035,"marketCap":201787643},{"date":"2022-05-27","current":-10.426695,"twenty":-13.392645,"median":-13.013378,"eighty":-11.61546,"marketCap":283084780},{"date":"2022-06-03","current":-11.20566,"twenty":-13.378727,"median":-12.769812,"eighty":-10.726847,"marketCap":304233677},{"date":"2022-06-10","current":-6.882048,"twenty":-13.265642,"median":-12.632679,"eighty":-9.433336,"marketCap":186847596},{"date":"2022-06-17","current":-6.081643,"twenty":-13.265642,"median":-12.334802,"eighty":-8.368513,"marketCap":165116619},{"date":"2022-06-24","current":-6.253159,"twenty":-13.196052,"median":-12.186994,"eighty":-7.795366,"marketCap":169773257},{"date":"2022-07-01","current":-5.831517,"twenty":-13.172482,"median":-12.113054,"eighty":-7.105018,"marketCap":158325689},{"date":"2022-07-08","current":-6.424674,"twenty":-13.15991,"median":-11.715613,"eighty":-6.370361,"marketCap":174429895},{"date":"2022-07-15","current":-6.360356,"twenty":-13.1369,"median":-11.019852,"eighty":-6.253159,"marketCap":172683656},{"date":"2022-07-22","current":-5.881542,"twenty":-13.116023,"median":-10.573198,"eighty":-6.184553,"marketCap":159683875},{"date":"2022-07-29","current":-6.117376,"twenty":-13.077749,"median":-9.433336,"eighty":-5.990169,"marketCap":166086752},{"date":"2022-08-05","current":-7.28225,"twenty":-13.051653,"median":-8.550748,"eighty":-5.92728,"marketCap":197713085},{"date":"2022-08-12","current":-11.654946,"twenty":-13.048173,"median":-8.368513,"eighty":-5.964441,"marketCap":376023512},{"date":"2022-08-19","current":-11.973683,"twenty":-13.048173,"median":-8.836607,"eighty":-5.990169,"marketCap":386306920},{"date":"2022-08-26","current":-9.447843,"twenty":-13.042954,"median":-9.447843,"eighty":-6.034477,"marketCap":304815757},{"date":"2022-09-02","current":-7.685769,"twenty":-13.039474,"median":-9.296256,"eighty":-6.073067,"marketCap":247965969},{"date":"2022-09-09","current":-5.683139,"twenty":-13.031725,"median":-8.930422,"eighty":-5.955866,"marketCap":183355118},{"date":"2022-09-16","current":-5.310277,"twenty":-13.017412,"median":-8.532882,"eighty":-5.851527,"marketCap":171325470},{"date":"2022-09-23","current":-6.735572,"twenty":-12.958334,"median":-8.22201,"eighty":-5.820083,"marketCap":217309769},{"date":"2022-09-30","current":-10.452165,"twenty":-12.87166,"median":-8.485618,"eighty":-5.827229,"marketCap":337218196},{"date":"2022-10-07","current":-10.758874,"twenty":-12.827224,"median":-8.662429,"eighty":-5.851527,"marketCap":347113551},{"date":"2022-10-14","current":-10.75286,"twenty":-12.732811,"median":-9.159176,"eighty":-5.887259,"marketCap":346919525},{"date":"2022-10-21","current":-9.868816,"twenty":-12.676035,"median":-9.377444,"eighty":-5.901552,"marketCap":318397617},{"date":"2022-10-28","current":-9.056939,"twenty":-12.658457,"median":-9.321551,"eighty":-5.921562,"marketCap":292204029},{"date":"2022-11-04","current":-9.604204,"twenty":-12.633134,"median":-9.294488,"eighty":-5.955866,"marketCap":309860448},{"date":"2022-11-11","current":-7.870305,"twenty":-12.51788,"median":-9.213301,"eighty":-5.98731,"marketCap":288517524},{"date":"2022-11-18","current":-6.891148,"twenty":-12.343378,"median":-9.131888,"eighty":-6.021613,"marketCap":252622607},{"date":"2022-11-25","current":-5.8326,"twenty":-12.30698,"median":-9.032884,"eighty":-5.94729,"marketCap":213817291},{"date":"2022-12-02","current":-5.102202,"twenty":-12.193952,"median":-8.756244,"eighty":-5.842388,"marketCap":187041623},{"date":"2022-12-09","current":-4.726417,"twenty":-12.185254,"median":-8.550748,"eighty":-5.80579,"marketCap":173265735},{"date":"2022-12-16","current":-5.181593,"twenty":-12.178295,"median":-8.404872,"eighty":-5.725749,"marketCap":189952021},{"date":"2022-12-23","current":-5.043982,"twenty":-12.152199,"median":-8.130215,"eighty":-5.685509,"marketCap":184907330},{"date":"2022-12-30","current":-5.043982,"twenty":-12.047813,"median":-8.043349,"eighty":-5.617123,"marketCap":184907330},{"date":"2023-01-06","current":-5.361546,"twenty":-11.988509,"median":-7.887149,"eighty":-5.544229,"marketCap":196548925},{"date":"2023-01-13","current":-5.642062,"twenty":-11.900765,"median":-7.790914,"eighty":-5.514548,"marketCap":206832334},{"date":"2023-01-20","current":-5.292741,"twenty":-11.857841,"median":-7.780329,"eighty":-5.486455,"marketCap":194026580},{"date":"2023-01-27","current":-6.652975,"twenty":-11.83416,"median":-7.52668,"eighty":-5.481434,"marketCap":243891411},{"date":"2023-02-03","current":-8.256675,"twenty":-11.724707,"median":-7.50379,"eighty":-5.486455,"marketCap":302681464},{"date":"2023-02-10","current":-7.621547,"twenty":-11.591193,"median":-7.550498,"eighty":-5.497097,"marketCap":279398275},{"date":"2023-02-17","current":-7.224591,"twenty":-11.42481,"median":-7.520984,"eighty":-5.503782,"marketCap":264846281},{"date":"2023-02-24","current":-6.409509,"twenty":-11.289301,"median":-7.50379,"eighty":-5.509499,"marketCap":234966188},{"date":"2023-03-03","current":-5.456816,"twenty":-11.208214,"median":-7.426374,"eighty":-5.509499,"marketCap":200041403},{"date":"2023-03-10","current":-4.578221,"twenty":-11.173685,"median":-7.303982,"eighty":-5.480511,"marketCap":167832991},{"date":"2023-03-17","current":-4.684075,"twenty":-11.125722,"median":-7.239128,"eighty":-5.439451,"marketCap":171713523},{"date":"2023-03-24","current":-5.493865,"twenty":-11.125722,"median":-7.16076,"eighty":-5.330785,"marketCap":201399590},{"date":"2023-03-31","current":-4.675853,"twenty":-11.084828,"median":-7.064148,"eighty":-5.270511,"marketCap":191504234},{"date":"2023-04-06","current":-4.230534,"twenty":-11.023486,"median":-6.924927,"eighty":-5.260984,"marketCap":173265735},{"date":"2023-04-14","current":-4.216321,"twenty":-11.019852,"median":-6.821303,"eighty":-5.202027,"marketCap":172683656},{"date":"2023-04-21","current":-4.007874,"twenty":-10.916914,"median":-6.735572,"eighty":-5.163355,"marketCap":164146486},{"date":"2023-04-28","current":-3.789856,"twenty":-10.785335,"median":-6.531871,"eighty":-5.110953,"marketCap":155217351},{"date":"2023-05-04","current":-2.741598,"twenty":-10.756468,"median":-6.516471,"eighty":-5.079973,"marketCap":112284892},{"date":"2023-05-12","current":-2.021591,"twenty":-10.742455,"median":-6.4889,"eighty":-5.044655,"marketCap":98297847},{"date":"2023-05-19","current":-3.128272,"twenty":-10.723989,"median":-6.417091,"eighty":-5.017615,"marketCap":152109119},{"date":"2023-05-26","current":-2.225348,"twenty":-10.658392,"median":-6.345996,"eighty":-4.977293,"marketCap":108205337},{"date":"2023-06-02","current":-2.385158,"twenty":-10.566429,"median":-6.281745,"eighty":-4.901078,"marketCap":115975918},{"date":"2023-06-09","current":-2.560948,"twenty":-10.530346,"median":-6.253159,"eighty":-4.858736,"marketCap":124523557},{"date":"2023-06-16","current":-2.916525,"twenty":-10.482234,"median":-6.179275,"eighty":-4.763467,"marketCap":141813099},{"date":"2023-06-23","current":-2.816644,"twenty":-10.458179,"median":-6.099509,"eighty":-4.692657,"marketCap":136956486},{"date":"2023-06-30","current":-3.356001,"twenty":-10.436883,"median":-6.046964,"eighty":-4.666378,"marketCap":163182196},{"date":"2023-07-07","current":-3.515811,"twenty":-10.412827,"median":-5.988739,"eighty":-4.546389,"marketCap":170952777},{"date":"2023-07-14","current":-3.096311,"twenty":-10.358348,"median":-5.938714,"eighty":-4.379111,"marketCap":150555003},{"date":"2023-07-21","current":-3.096311,"twenty":-10.284978,"median":-5.895835,"eighty":-4.25703,"marketCap":150555003},{"date":"2023-07-28","current":-3.268106,"twenty":-10.193567,"median":-5.832059,"eighty":-4.205213,"marketCap":158908377},{"date":"2023-08-04","current":-3.216168,"twenty":-10.158686,"median":-5.817224,"eighty":-4.029666,"marketCap":156382938},{"date":"2023-08-11","current":-3.356001,"twenty":-10.014353,"median":-5.791146,"eighty":-3.845856,"marketCap":163182196},{"date":"2023-08-18","current":-5.688753,"twenty":-9.981877,"median":-5.731467,"eighty":-3.79935,"marketCap":308944792},{"date":"2023-08-25","current":-8.204932,"twenty":-9.916927,"median":-5.791146,"eighty":-3.845856,"marketCap":445593450},{"date":"2023-09-01","current":-8.226812,"twenty":-9.859194,"median":-5.817224,"eighty":-3.898925,"marketCap":446781699},{"date":"2023-09-08","current":-8.50578,"twenty":-9.820705,"median":-5.831517,"eighty":-3.974712,"marketCap":461931876},{"date":"2023-09-15","current":-7.915024,"twenty":-9.604204,"median":-5.888688,"eighty":-4.007874,"marketCap":429849148},{"date":"2023-09-22","current":-7.554007,"twenty":-9.586163,"median":-5.938714,"eighty":-4.029192,"marketCap":410243036},{"date":"2023-09-29","current":-8.730048,"twenty":-9.561973,"median":-5.988739,"eighty":-4.031561,"marketCap":474111430},{"date":"2023-10-06","current":-8.292451,"twenty":-9.447843,"median":-6.060204,"eighty":-4.121573,"marketCap":450346446},{"date":"2023-10-13","current":-8.068183,"twenty":-9.447843,"median":-6.108187,"eighty":-4.154735,"marketCap":438166892},{"date":"2023-10-20","current":-7.958784,"twenty":-9.433336,"median":-6.21897,"eighty":-4.202436,"marketCap":432225646},{"date":"2023-10-27","current":-8.062713,"twenty":-9.388622,"median":-6.246012,"eighty":-4.20799,"marketCap":437869830},{"date":"2023-11-03","current":-8.204932,"twenty":-9.299901,"median":-6.263879,"eighty":-4.222006,"marketCap":445593450},{"date":"2023-11-10","current":-8.42373,"twenty":-9.245776,"median":-6.345996,"eighty":-4.238114,"marketCap":457475942},{"date":"2023-11-17","current":-8.188416,"twenty":-9.191651,"median":-6.417091,"eighty":-4.251835,"marketCap":488651941},{"date":"2023-11-24","current":-8.592106,"twenty":-9.159176,"median":-6.462436,"eighty":-4.25703,"marketCap":512742511},{"date":"2023-12-01","current":-8.756572,"twenty":-9.148261,"median":-6.515364,"eighty":-4.263696,"marketCap":522557188},{"date":"2023-12-08","current":-9.369582,"twenty":-9.256601,"median":-6.592423,"eighty":-4.286376,"marketCap":559139166},{"date":"2023-12-15","current":-10.181945,"twenty":-9.420585,"median":-6.735572,"eighty":-4.378104,"marketCap":607617721},{"date":"2023-12-22","current":-10.216831,"twenty":-9.539147,"median":-6.886598,"eighty":-4.40653,"marketCap":609699622},{"date":"2023-12-29","current":-10.416184,"twenty":-9.612102,"median":-6.924927,"eighty":-4.479724,"marketCap":621596200},{"date":"2024-01-05","current":-9.638708,"twenty":-9.641698,"median":-7.064148,"eighty":-4.516825,"marketCap":575199546},{"date":"2024-01-12","current":-10.431136,"twenty":-9.849572,"median":-7.123402,"eighty":-4.535879,"marketCap":622488443},{"date":"2024-01-19","current":-9.892883,"twenty":-9.923734,"median":-7.161078,"eighty":-4.541134,"marketCap":590367683},{"date":"2024-01-26","current":-9.912818,"twenty":-9.910825,"median":-7.239128,"eighty":-4.565367,"marketCap":591557341},{"date":"2024-02-02","current":-9.937737,"twenty":-9.925728,"median":-7.28225,"eighty":-4.59301,"marketCap":593044413},{"date":"2024-02-09","current":-9.96764,"twenty":-9.966643,"median":-7.362202,"eighty":-4.656903,"marketCap":594828900},{"date":"2024-02-16","current":-1.918771,"twenty":-9.966643,"median":-7.303982,"eighty":-4.541134,"marketCap":114504563},{"date":"2024-02-23","current":-1.649644,"twenty":-9.962656,"median":-7.2641,"eighty":-4.382132,"marketCap":98444182},{"date":"2024-03-01","current":-1.485178,"twenty":-9.942721,"median":-7.216995,"eighty":-4.255363,"marketCap":88629506},{"date":"2024-03-08","current":-1.465243,"twenty":-9.937737,"median":-7.16076,"eighty":-4.202436,"marketCap":87439848},{"date":"2024-03-15","current":-1.515081,"twenty":-9.928955,"median":-7.0934,"eighty":-4.029192,"marketCap":90413992},{"date":"2024-03-22","current":-1.649644,"twenty":-9.912818,"median":-6.924927,"eighty":-3.837326,"marketCap":98444182},{"date":"2024-03-28","current":-1.60479,"twenty":-9.904844,"median":-6.882048,"eighty":-3.54138,"marketCap":95767452},{"date":"2024-04-05","current":-1.493229,"twenty":-9.894877,"median":-6.735572,"eighty":-3.40709,"marketCap":96659696},{"date":"2024-04-12","current":-1.379706,"twenty":-9.873629,"median":-6.531871,"eighty":-3.34002,"marketCap":89311125},{"date":"2024-04-19","current":-1.094567,"twenty":-9.830327,"median":-6.512717,"eighty":-3.300068,"marketCap":70853492},{"date":"2024-04-26","current":-1.048577,"twenty":-9.7389,"median":-6.435973,"eighty":-3.275297,"marketCap":67876455},{"date":"2024-05-03","current":-1.170453,"twenty":-9.714462,"median":-6.384932,"eighty":-3.243335,"marketCap":75765761},{"date":"2024-05-10","current":-1.138196,"twenty":-9.689543,"median":-6.288891,"eighty":-3.200986,"marketCap":73677728},{"date":"2024-05-17","current":-1.025534,"twenty":-9.683563,"median":-6.253159,"eighty":-3.153842,"marketCap":67711920},{"date":"2024-05-24","current":-0.908072,"twenty":-9.651666,"median":-6.21897,"eighty":-3.096311,"marketCap":59956370},{"date":"2024-05-31","current":-0.899037,"twenty":-9.640702,"median":-6.117376,"eighty":-3.032764,"marketCap":59359789},{"date":"2024-06-07","current":-0.917108,"twenty":-9.626747,"median":-6.070923,"eighty":-2.970061,"marketCap":60552951},{"date":"2024-06-14","current":-0.980356,"twenty":-9.610032,"median":-5.995886,"eighty":-2.875774,"marketCap":64729016},{"date":"2024-06-21","current":-0.95325,"twenty":-9.596988,"median":-5.970211,"eighty":-2.763626,"marketCap":62939274},{"date":"2024-06-28","current":-0.971321,"twenty":-9.576487,"median":-5.902982,"eighty":-2.560948,"marketCap":64132436},{"date":"2024-07-05","current":-1.188174,"twenty":-9.555391,"median":-5.857071,"eighty":-2.458418,"marketCap":78450375},{"date":"2024-07-12","current":-1.165585,"twenty":-9.514113,"median":-5.824371,"eighty":-2.36598,"marketCap":76958923},{"date":"2024-07-19","current":-1.260458,"twenty":-9.453014,"median":-5.802931,"eighty":-2.238133,"marketCap":83223021},{"date":"2024-07-26","current":-1.210763,"twenty":-9.447843,"median":-5.737331,"eighty":-2.128663,"marketCap":79941827},{"date":"2024-08-02","current":-1.165585,"twenty":-9.447142,"median":-5.721772,"eighty":-1.927742,"marketCap":76958923},{"date":"2024-08-09","current":-0.46533,"twenty":-9.442138,"median":-5.694989,"eighty":-1.744863,"marketCap":30723911},{"date":"2024-08-16","current":-0.452319,"twenty":-9.420585,"median":-5.683771,"eighty":-1.649644,"marketCap":29245582},{"date":"2024-08-23","current":-0.507705,"twenty":-9.368585,"median":-5.668525,"eighty":-1.569679,"marketCap":32826674},{"date":"2024-08-30","current":-0.521551,"twenty":-9.363601,"median":-5.629593,"eighty":-1.541673,"marketCap":33721947},{"date":"2024-09-06","current":-0.470781,"twenty":-9.359614,"median":-5.566854,"eighty":-1.505114,"marketCap":30439279},{"date":"2024-09-13","current":-0.480012,"twenty":-9.321551,"median":-5.545658,"eighty":-1.493229,"marketCap":31036128},{"date":"2024-09-20","current":-0.484627,"twenty":-9.274889,"median":-5.510762,"eighty":-1.470227,"marketCap":31334552},{"date":"2024-09-27","current":-0.489243,"twenty":-9.269905,"median":-5.493865,"eighty":-1.445308,"marketCap":31632976},{"date":"2024-10-04","current":-0.493858,"twenty":-9.267426,"median":-5.480973,"eighty":-1.398102,"marketCap":31931401},{"date":"2024-10-11","current":-0.484627,"twenty":-9.213301,"median":-5.440937,"eighty":-1.379706,"marketCap":31334552},{"date":"2024-10-18","current":-0.484627,"twenty":-9.159176,"median":-5.400004,"eighty":-1.260458,"marketCap":31334552},{"date":"2024-10-25","current":-0.493858,"twenty":-9.159176,"median":-5.292741,"eighty":-1.224316,"marketCap":31931401},{"date":"2024-11-01","current":-0.498474,"twenty":-9.104599,"median":-5.27157,"eighty":-1.192692,"marketCap":32229825},{"date":"2024-11-08","current":-0.507705,"twenty":-9.056939,"median":-5.260984,"eighty":-1.175061,"marketCap":32826674},{"date":"2024-11-15","current":-0.492263,"twenty":-9.008828,"median":-5.223935,"eighty":-1.165585,"marketCap":29878890},{"date":"2024-11-22","current":-0.659632,"twenty":-8.984772,"median":-5.186886,"eighty":-1.152032,"marketCap":40037712},{"date":"2024-11-29","current":-0.822079,"twenty":-8.833504,"median":-5.165715,"eighty":-1.14661,"marketCap":49897746},{"date":"2024-12-06","current":-0.708859,"twenty":-8.764395,"median":-5.131312,"eighty":-1.135958,"marketCap":43025601},{"date":"2024-12-13","current":-0.703936,"twenty":-8.75631,"median":-5.107495,"eighty":-1.128429,"marketCap":42726812},{"date":"2024-12-20","current":-0.620251,"twenty":-8.752791,"median":-5.06243,"eighty":-1.10594,"marketCap":37647401},{"date":"2024-12-27","current":-0.708859,"twenty":-8.7388,"median":-5.051921,"eighty":-1.093587,"marketCap":43025601},{"date":"2025-01-03","current":-0.699014,"twenty":-8.706848,"median":-5.044823,"eighty":-1.083887,"marketCap":42428023},{"date":"2025-01-10","current":-0.615329,"twenty":-8.669427,"median":-5.041335,"eighty":-1.044599,"marketCap":37348612},{"date":"2025-01-17","current":-0.625174,"twenty":-8.655656,"median":-5.006933,"eighty":-1.011077,"marketCap":37946190},{"date":"2025-01-24","current":-0.615329,"twenty":-8.642528,"median":-4.99154,"eighty":-0.978098,"marketCap":37348612},{"date":"2025-01-31","current":-0.56118,"twenty":-8.620649,"median":-4.940774,"eighty":-0.957768,"marketCap":34061934},{"date":"2025-02-07","current":-0.531644,"twenty":-8.592106,"median":-4.895785,"eighty":-0.948732,"marketCap":32269201},{"date":"2025-02-14","current":-0.551335,"twenty":-8.592106,"median":-4.864028,"eighty":-0.935179,"marketCap":33464356},{"date":"2025-02-21","current":-0.556257,"twenty":-8.573312,"median":-4.805808,"eighty":-0.928854,"marketCap":33763145},{"date":"2025-02-28","current":-0.56118,"twenty":-8.566482,"median":-4.763467,"eighty":-0.907168,"marketCap":34061934},{"date":"2025-03-07","current":-0.644865,"twenty":-8.539495,"median":-4.726229,"eighty":-0.899037,"marketCap":39141345},{"date":"2025-03-14","current":-0.689168,"twenty":-8.528704,"median":-4.684075,"eighty":-0.782698,"marketCap":41830446},{"date":"2025-03-21","current":-0.718704,"twenty":-8.510156,"median":-4.66401,"eighty":-0.732487,"marketCap":43623179},{"date":"2025-03-28","current":-0.815207,"twenty":-8.48965,"median":-4.562154,"eighty":-0.73741,"marketCap":41837220},{"date":"2025-04-04","current":-0.744829,"twenty":-8.484244,"median":-4.520001,"eighty":-0.742333,"marketCap":38225374},{"date":"2025-04-11","current":-0.750694,"twenty":-8.45484,"median":-4.377097,"eighty":-0.733398,"marketCap":38526361},{"date":"2025-04-17","current":-0.738964,"twenty":-8.433268,"median":-4.263696,"eighty":-0.736426,"marketCap":37924387},{"date":"2025-04-25","current":-0.7331,"twenty":-8.412415,"median":-4.240009,"eighty":-0.733323,"marketCap":37623400},{"date":"2025-05-02","current":-0.715505,"twenty":-8.383057,"median":-4.202436,"eighty":-0.728023,"marketCap":36720438},{"date":"2025-05-09","current":-0.703776,"twenty":-8.368106,"median":-4.076567,"eighty":-0.727235,"marketCap":36118464},{"date":"2025-05-16","current":-0.803022,"twenty":-8.352142,"median":-4.007874,"eighty":-0.727235,"marketCap":36419451},{"date":"2025-05-23","current":-0.789749,"twenty":-8.341681,"median":-3.858652,"eighty":-0.727235,"marketCap":35817476},{"date":"2025-05-30","current":-0.805076,"twenty":-8.337305,"median":-3.749538,"eighty":-0.727235,"marketCap":36512621},{"date":"2025-06-06","current":-0.738541,"twenty":-8.328553,"median":-3.531792,"eighty":-0.727235,"marketCap":33495049},{"date":"2025-06-13","current":-0.751848,"twenty":-8.312143,"median":-3.453864,"eighty":-0.727235,"marketCap":34098563},{"date":"2025-06-20","current":-0.731887,"twenty":-8.285296,"median":-3.37993,"eighty":-0.727235,"marketCap":33193292},{"date":"2025-06-27","current":-0.71858,"twenty":-8.255078,"median":-3.34002,"eighty":-0.72001,"marketCap":32589777},{"date":"2025-07-03","current":-0.69862,"twenty":-8.248692,"median":-3.308058,"eighty":-0.71858,"marketCap":31684506},{"date":"2025-07-11","current":-0.711927,"twenty":-8.237752,"median":-3.300068,"eighty":-0.715505,"marketCap":32288020},{"date":"2025-07-18","current":-0.725234,"twenty":-8.232282,"median":-3.276096,"eighty":-0.715505,"marketCap":32891534},{"date":"2025-07-25","current":-0.731887,"twenty":-8.226812,"median":-3.270104,"eighty":-0.715505,"marketCap":33193292},{"date":"2025-08-01","current":-0.705273,"twenty":-8.204932,"median":-3.244134,"eighty":-0.713781,"marketCap":31986263},{"date":"2025-08-08","current":-0.71858,"twenty":-8.204932,"median":-3.210175,"eighty":-0.711927,"marketCap":32589777},{"date":"2025-08-15","current":-0.771244,"twenty":-8.199462,"median":-3.188201,"eighty":-0.711927,"marketCap":28829104},{"date":"2025-08-22","current":-0.811451,"twenty":-8.188416,"median":-3.162232,"eighty":-0.711927,"marketCap":30332043},{"date":"2025-08-29","current":-0.804141,"twenty":-8.18787,"median":-3.120282,"eighty":-0.713781,"marketCap":30058781},{"date":"2025-09-05","current":-0.921107,"twenty":-8.185512,"median":-3.096311,"eighty":-0.714959,"marketCap":34430967},{"date":"2025-09-12","current":-0.928417,"twenty":-8.183731,"median":-3.036031,"eighty":-0.715455,"marketCap":34704229},{"date":"2025-09-19","current":-0.943038,"twenty":-8.171471,"median":-3.008415,"eighty":-0.715505,"marketCap":35250752},{"date":"2025-09-26","current":-0.906486,"twenty":-8.162634,"median":-2.968463,"eighty":-0.715505,"marketCap":33884444},{"date":"2025-10-03","current":-0.935727,"twenty":-8.156796,"median":-2.88656,"eighty":-0.717965,"marketCap":34977491},{"date":"2025-10-10","current":-0.906486,"twenty":-8.151327,"median":-2.842613,"eighty":-0.71858,"marketCap":33884444},{"date":"2025-10-17","current":-0.862624,"twenty":-8.145857,"median":-2.741598,"eighty":-0.71858,"marketCap":32244874},{"date":"2025-10-24","current":-0.855313,"twenty":-8.140387,"median":-2.608584,"eighty":-0.71858,"marketCap":31971613},{"date":"2025-10-31","current":-0.906486,"twenty":-8.138721,"median":-2.541748,"eighty":-0.71858,"marketCap":33884444},{"date":"2025-11-07","current":-0.818761,"twenty":-8.134774,"median":-2.431944,"eighty":-0.71858,"marketCap":30605304},{"date":"2025-11-14","current":-0.826072,"twenty":-8.105379,"median":-2.385158,"eighty":-0.71858,"marketCap":30878566},{"date":"2025-11-21","current":-0.870776,"twenty":-8.0895,"median":-2.290271,"eighty":-0.71858,"marketCap":29594185},{"date":"2025-11-28","current":-0.878839,"twenty":-8.087308,"median":-2.239332,"eighty":-0.718654,"marketCap":29868206},{"date":"2025-12-05","current":-0.858682,"twenty":-8.080228,"median":-2.177405,"eighty":-0.718704,"marketCap":29183155},{"date":"2025-12-12","current":-0.959466,"twenty":-8.07122,"median":-2.079522,"eighty":-0.718704,"marketCap":32608408},{"date":"2025-12-18","current":-0.911089,"twenty":-8.06829,"median":-1.982641,"eighty":-0.721316,"marketCap":30964287}],"updateTime":1766172316948},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ANTX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2583583613","title":"AN2 Therapeutics Advances Chagas Disease and Oncology Programs and Reports Third Quarter 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2583583613","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583583613?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:20","pubTimestamp":1762982424,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics Inc. announced its third quarter 2025 financial results and recent business and scientific highlights. The company reported ongoing progress in its clinical pipeline, including the advancement of a Phase 1 first-in-human clinical trial for oral AN2-502998 targeting Chagas disease, with planning underway for a subsequent Phase 2 proof-of-concept study in collaboration with the Drugs for Neglected Diseases initiative . The clinical-stage M. abscessus program is advancing through an investigator-initiated trial. In oncology, AN2 expects its first of two boron-based oncology targets to enter development in early 2026, with both programs aimed at solid-tumor cancers. AN2 also announced a research collaboration with GSK to develop boron-based LeuRS-inhibitors for tuberculosis  and received a third year of funding from the Gates Foundation to support this work.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL3PbMgJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX","BK4007"],"gpt_icon":0},{"id":"2583958369","title":"AN2 Therapeutics Q3 net loss narrows to $9.4 mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2583958369","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583958369?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:19","pubTimestamp":1762982361,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics Q3 net loss narrows to $9.4 mlnOverviewAN2 Therapeutics reports Q3 net loss of $9.4 mln, improved from $12.7 mln last yearCompany's R&D expenses decreased to $7 mln from $8.3 mln in Q","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nL1N3WO12U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX","BK4007"],"gpt_icon":0},{"id":"2583459300","title":"Press Release: AN2 Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business and Scientific Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2583459300","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583459300?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:01","pubTimestamp":1762981260,"startTime":"0","endTime":"0","summary":"Advancing Phase 1 program in Chagas Disease; Phase 2 planning underway. Clinical-stage M. abscessus program advancing through investigator-initiated trial . First of two boron-based oncology targets to enter development in early 2026. Announced research collaboration with GSK to advance boron-based LeuRS-inhibitors targeting tuberculosis . AN2 awarded third year of funding from Gates Foundation. AN2 Therapeutics, Inc. , a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today reported financial results for the third quarter ended September 30, 2025.genetic types. Because NHP infections are naturally acquired in the","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANTX","SOC","LENZ","BK4007","BK4213","BK4539"],"gpt_icon":0},{"id":"2582803217","title":"REFILE-BUZZ-U.S. STOCKS ON THE MOVE-Guardant Health, Tower Semiconductor, GlobalFoundries","url":"https://stock-news.laohu8.com/highlight/detail?id=2582803217","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582803217?lang=en_us&edition=fundamental","pubTime":"2025-11-11 00:14","pubTimestamp":1762791244,"startTime":"0","endTime":"0","summary":"REFILE-BUZZ-U.S. STOCKS ON THE MOVE-Guardant Health, Tower Semiconductor, GlobalFoundriesCorrects typo in headlineEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https:/","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nL6N3WM0TV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOC",".IXIC","TSN","LU2505996509.AUD","CART","AAL","GH","SGXZ99366536.SGD","MOH","HHH","DAL","BK4017","LUV","COGT","BK4532","HL","LU0630314457.HKD","MGTX","ELV","LU0878866978.SGD","RNGR","LU0114720955.EUR","LC","IE00BKPKM429.USD","RGLD","CDE","NEM","UAL","RIOT","CNH","VG","SGXZ58947870.SGD","PSQH","CNC","STRK","GFS","ANTX","MNKD","LU0353189680.USD","THS"],"gpt_icon":1},{"id":"2582181872","title":"BUZZ-U.S. STOCKS ON THE MOVE-Instacart, Plug Power, Crypto stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2582181872","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582181872?lang=en_us&edition=fundamental","pubTime":"2025-11-10 22:10","pubTimestamp":1762783829,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Instacart, Plug Power, Crypto stocksEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslette","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nL6N3WM0L6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CART","PLUG","ELV","THS","ANTX","LU2347655156.SGD","MOH","HL","RNGR","LUV","LU1548497426.USD","MGTX","SG9999014021.USD","LU1815333072.USD","IE00B4JS1V06.HKD","LU1066051498.USD","RGLD","LU0672654240.SGD","LU0505663152.USD","PSQH","IE00B7SZLL34.SGD","NEM","BK4112","COGT","LU2089283258.USD","LU2264538146.SGD","TSN","AAL",".IXIC","RIOT","CDE","LU0683600562.USD","LU2279689827.SGD","DAL","STRK","VG","HHH","CNC","UAL","BK4179","IE00BFXG1179.USD"],"gpt_icon":1},{"id":"2582872695","title":"AN2 Therapeutics, GSK Collaborate to Develop New Therapies for Tuberculosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2582872695","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582872695?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:58","pubTimestamp":1762783112,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics (ANTX) said Monday the company has signed a collaboration agreement with GSK (GSK) to develop new therapies for tuberculosis.Financial details of the collaboration agreement weren't disclosed.Shares of AN2 Therapeutics were up over 1% in recent Monday premarket activity.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4139","BK4585","GSK","GSK.UK","BK4007","LENZ","ANTX","BK4539","LU1829250122.USD","BK4532"],"gpt_icon":0},{"id":"2582871508","title":"Shares of AN2 Therapeutics up 1.8% After GSK Collaboration to Develop Tuberculosis Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2582871508","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582871508?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:14","pubTimestamp":1762780453,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nFWN3WM0WP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANTX"],"gpt_icon":0},{"id":"2582774873","title":"BRIEF-AN2 Therapeutics Announces Research Collaboration With GSK","url":"https://stock-news.laohu8.com/highlight/detail?id=2582774873","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582774873?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:09","pubTimestamp":1762776559,"startTime":"0","endTime":"0","summary":"BRIEF-AN2 Therapeutics Announces Research Collaboration With GSKNov 10 (Reuters) - AN2 Therapeutics Inc ANTX.O:AN2 THERAPEUTICS ANNOUNCES RESEARCH COLLABORATION WITH GSK TO ADVANCE BORON-BASED LEURS-I","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nTUA8Q5PGQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX","BK4007"],"gpt_icon":0},{"id":"2582669873","title":"AN2 Therapeutics Partners with GSK to Develop Boron-Based Tuberculosis Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2582669873","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582669873?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:00","pubTimestamp":1762776053,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics Inc. has announced a research collaboration with global biopharma company GSK to advance boron-based LeuRS-inhibitors targeting tuberculosis . The initiative is further supported by a third year of funding from the Gates Foundation. This partnership aims to develop innovative therapies for TB, leveraging AN2's boron chemistry platform and GSK's expertise in global health. The collaboration seeks to address the urgent unmet needs in TB treatment, particularly for patients in lower income countries.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AN2 Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on November 10, 2025, and is solely responsible for the information conta","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL9lnVqT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX","BK4007"],"gpt_icon":0},{"id":"2582878007","title":"AN2 Therapeutics Announces Research Collaboration With GSK to Advance Boron-Based Leurs-Inhibitors Targeting Tuberculosis (Tb)","url":"https://stock-news.laohu8.com/highlight/detail?id=2582878007","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582878007?lang=en_us&edition=fundamental","pubTime":"2025-11-10 20:00","pubTimestamp":1762776001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nTUA8Q5PGQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANTX"],"gpt_icon":0},{"id":"2581044550","title":"AN2 Therapeutics Inc. Officer Joshua M. Eizen Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2581044550","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581044550?lang=en_us&edition=fundamental","pubTime":"2025-11-07 07:12","pubTimestamp":1762470760,"startTime":"0","endTime":"0","summary":"Joshua M. Eizen, an officer of AN2 Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AN2 Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 06, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL81HzhQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"AN2 Therapeutics Inc. Officer Joshua M. Eizen Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANTX"],"gpt_icon":0},{"id":"2581046628","title":"AN2 Therapeutics CEO to Join Fireside Chat at Evercore HealthCONx Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2581046628","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581046628?lang=en_us&edition=fundamental","pubTime":"2025-11-07 06:03","pubTimestamp":1762466603,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics Inc. will participate in a fireside chat at the 8th Annual Evercore HealthCONx Conference on December 3, 2025. Eric Easom, Co-Founder, Chairman, President and CEO, will represent the company, and management will also be available for one-on-one meetings.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AN2 Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on November 06, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL1GtY21:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANTX","EVR","BK4127"],"gpt_icon":0},{"id":"2580973412","title":"AN2 Therapeutics Inc  expected to post a loss of 22 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2580973412","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580973412?lang=en_us&edition=fundamental","pubTime":"2025-11-01 06:34","pubTimestamp":1761950045,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics Inc  expected to post a loss of22cents a share - Earnings Preview AN2 Therapeutics Inc ANTX.OQ ANTX.O is expected to  show no change in quarterly revenue when it reports  results on N","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nL8N3WC2KH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX","BK4007"],"gpt_icon":0},{"id":"2578958240","title":"AN2 Therapeutics Gains 11%, Insider Trades Reap Benefit","url":"https://stock-news.laohu8.com/highlight/detail?id=2578958240","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578958240?lang=en_us&edition=fundamental","pubTime":"2025-10-28 18:01","pubTimestamp":1761645689,"startTime":"0","endTime":"0","summary":"Insiders who bought AN2 Therapeutics, Inc. ( NASDAQ:ANTX ) stock in the last 12 months were richly rewarded last week...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-antx/an2-therapeutics/news/an2-therapeutics-gains-11-insider-trades-reap-benefit","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-antx/an2-therapeutics/news/an2-therapeutics-gains-11-insider-trades-reap-benefit","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","BK4007","ANTX","LENZ","BK4539"],"gpt_icon":0},{"id":"2559762454","title":"AN2 Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2559762454","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559762454?lang=en_us&edition=fundamental","pubTime":"2025-08-13 04:52","pubTimestamp":1755031967,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics Inc reports results for the quarter ended June 30 - Earnings SummaryAN2 Therapeutics Inc ANTX.OQ reported a quarterly adjusted loss of 21 cents per share for the quarter ended June 30","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nL8N3U41YJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX"],"gpt_icon":0},{"id":"2559629135","title":"AN2 Therapeutics Reports Q2 2025: Net Loss Decreases to $6.5M, Interest Income Drops Amid Lower Cash Balances","url":"https://stock-news.laohu8.com/highlight/detail?id=2559629135","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559629135?lang=en_us&edition=fundamental","pubTime":"2025-08-13 04:01","pubTimestamp":1755028917,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AN2 Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on August 12, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nNDL8LR5Sp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANTX"],"gpt_icon":0},{"id":"2558649905","title":"AN2 Therapeutics Initiates First-in-Human Clinical Trial for Potential Chagas Disease Cure, AN2-502998","url":"https://stock-news.laohu8.com/highlight/detail?id=2558649905","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558649905?lang=en_us&edition=fundamental","pubTime":"2025-08-12 19:01","pubTimestamp":1754996489,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics Inc. has announced the commencement of its first-in-human clinical trial for the drug candidate AN2-502998, intended for the treatment of chronic Chagas disease. This Phase 1 trial aims to evaluate the safety, tolerability, and pharmacokinetics of the oral drug in healthy volunteers. Preclinical studies in nonhuman primates have indicated AN2-502998's potential to cure chronic Chagas disease. With no FDA-approved treatment available for adults with the disease, this development is significant. The company plans to complete Phase 1 dosing by the end of 2025. In collaboration with the Drugs for Neglected Diseases initiative, AN2 Therapeutics is also preparing for a Phase 2 trial, anticipated to start in 2026, with data expected in 2027. Results from the current Phase 1 trial have not yet been presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nNDLzTl8w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ANTX"],"gpt_icon":0},{"id":"2558864934","title":"AN2 Therapeutics Commences First-in-Human Clinical Trial of Oral AN2-502998 for Chagas Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2558864934","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558864934?lang=en_us&edition=fundamental","pubTime":"2025-08-12 19:00","pubTimestamp":1754996400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nTUA302S5Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANTX"],"gpt_icon":0},{"id":"2558608649","title":"AN2 Therapeutics - Phase 2 Planning Underway With Dndi Collaboration; Initiation Expected in 2026, Data in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2558608649","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558608649?lang=en_us&edition=fundamental","pubTime":"2025-08-12 19:00","pubTimestamp":1754996400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nTUA302S5Y:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ANTX"],"gpt_icon":0},{"id":"2555402436","title":"AN2 Therapeutics Inc  expected to post a loss of 33 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2555402436","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555402436?lang=en_us&edition=fundamental","pubTime":"2025-07-31 04:10","pubTimestamp":1753906204,"startTime":"0","endTime":"0","summary":"AN2 Therapeutics Inc  expected to post a loss of33cents a share - Earnings Preview AN2 Therapeutics Inc ANTX.OQ ANTX.O is expected to  show no change in quarterly revenue when it reports  results on A","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250730:nL8N3TR2VC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANTX"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":31,"code":"91000000","status":"200"}]}}